Core Viewpoint - Medaro Mining Corp. has successfully closed a non-brokered private placement, raising gross proceeds of $976,100.18, which will be utilized for exploration activities and general corporate purposes [1][3]. Group 1: Private Placement Details - The private placement consisted of two parts: 2,387,000 non-flow-through units (NFT Units) priced at $0.30 per unit and 684,211 flow-through units (FT Units) priced at $0.38 per unit [9]. - The company paid a total of $68,327.01 in cash finder's fees and issued 167,090 non-transferable non-flow-through finder's warrants at an exercise price of $0.45, and 47,894 flow-through finder's warrants at an exercise price of $0.55, both valid for 36 months [1][9]. - The common share purchase warrants for both NFT and FT Units are now exercisable for a period of 36 months from the date of issuance, an extension from the previously announced 24 months [2]. Group 2: Use of Proceeds - The net proceeds from the private placement will be directed towards advancing exploration activities at the Sweden Property and Clay Howells West Property in Ontario, as well as covering general corporate and administrative expenses [3]. - The gross proceeds from the sale of FT Units will specifically be allocated to incur "Canadian exploration expenses" as defined by the Income Tax Act (Canada) [3]. Group 3: Regulatory and Compliance Information - All securities issued in connection with the private placement are subject to a statutory four-month hold period in accordance with applicable securities laws [4]. - The securities have not been registered under the U.S. Securities Act and cannot be offered or sold in the United States without proper registration or exemption [5].

Vancouver, British Columbia--(Newsfile Corp. - February 25, 2026) - Sun Summit Minerals Corp. (TSXV: SMN) (OTCQB: SMREF) ("Sun Summit" or the "Company") is pleased to announce that the TSX Venture Exchange (the "TSXV") has accepted for listing up to 102,583,760 common share purchase warrants of the Company (the "Warrants") for trading on the TSXV. The Warrants are expected to commence trading on the TSXV at the open of markets on February 27, 2026 under the trading symbol "SMN.WT". The Warrants were issued ...

Vancouver, British Columbia--(Newsfile Corp. - February 23, 2026) - Highway 50 Gold Corp. (TSXV: HWY) (the "Company") is pleased to announce that it has increased the size of its non-brokered private placement previously announced on February 18, 2026 (the "Offering"). The Company will now raise gross proceeds of up to $2,100,000 in the Offering via the issuance of up to 5,250,000 units (each, a "Unit") of the Company at a purchase price of $0.40 per Unit. Each Unit will consist of one common share of the ...

FRANKLIN, IN / ACCESS Newswire / February 20, 2026 / IBC Advanced Alloys Corp. ("IBC" or the "Company") (TSXV:IB)(OTCQB:IAALF) announces that it has closed on initial funding under the previously announced convertible security funding agreement (the "Agreement") with Lind Global Fund III, LP, managed by The Lind Partners, LLC, a New York based institutional fund manager (together, the "Investor" or "Lind"). Under the Agreement, Lind advanced to the Company US$1,250,000 (C$1,702,125), less a closing fee of U ...

Core Viewpoint - Trinity One Metals Ltd. is initiating a non-brokered private placement to raise up to C$3,300,000 by selling 16,500,000 units at C$0.20 each, aimed at advancing exploration and project activities across its mineral asset portfolio [1][3]. Offering Details - Each unit consists of one common share and one warrant, with the warrant allowing the purchase of an additional common share at C$0.30 for 36 months post-closing, with a 60-day exercise restriction [2]. - The offering is expected to close around February 27, 2026, subject to regulatory approvals, and may be completed in multiple tranches [6]. Use of Proceeds - The net proceeds will be allocated to exploration, technical evaluation, project advancement, verification of recently acquired properties, historical data verification, target generation, early-stage field programs, and general working capital [3]. Regulatory Compliance - The offering will comply with National Instrument 45-106 and will be available to purchasers in all Canadian provinces and territories, excluding Québec, under the Listed Issuer Financing Exemption [4]. Finder's Fees - Finder's fees may be paid up to 6.0% of the gross proceeds, and non-transferable warrants may be issued to finders equal to 6.0% of the units sold [6].

Core Viewpoint - Halcones Precious Metals Corp. has received approval from the TSX Venture Exchange to extend the expiry dates of 61,759,638 common share purchase warrants, maintaining the exercise price at $0.10 per share [1]. Company Overview - Halcones Precious Metals Corp. is focused on exploring and developing gold-silver projects in Chile, supported by a team with a strong background in exploration success in the region [2]. Warrant Details - A total of 30,481,462 common share purchase warrants (the "2023 Warrants") have had their expiry dates extended to July 14, 2027, July 19, 2027, July 31, 2027, and August 18, 2027, respectively [4]. - The 10,600,000 common share purchase warrants (the "2024 Warrants") issued in August 2024 now have an extended expiry date of August 26, 2028 [4]. - The 20,678,176 common share purchase warrants (the "2025 Warrants") issued as part of a LIFE offering and private placement have had their expiry dates extended to March 27, 2029, April 10, 2029, and May 2, 2029, respectively [4].

Core Viewpoint - Sorrento Resources Ltd. is conducting a non-brokered private placement to raise up to CDN$2,000,000 through the issuance of 8,000,000 units at CDN$0.25 per unit [1]. Group 1: Offering Details - Each unit consists of one common share and one common share purchase warrant, with the warrant exercisable at $0.35 per share for 24 months from closing [2]. - The offering is being conducted under the LIFE Exemption, allowing it to be offered to purchasers in all Canadian provinces except Quebec, with no hold period for the issued units [3]. - The company may pay a finder's fee of up to 6% of the gross proceeds and issue non-transferable warrants equal to 6% of the units sold, also exercisable at $0.35 [4]. Group 2: Use of Proceeds and Closing - The net proceeds from the offering will be allocated for exploration expenditures, marketing, promotion, and general working capital [5]. - The offering is expected to close on or about February 27, 2026, subject to necessary approvals, including from the Canadian Securities Exchange [5]. Group 3: Company Overview - Sorrento Resources Ltd. focuses on the acquisition, exploration, and development of mineral properties in Canada, including projects like Bottom Brook, Rodgers Cove Gold, and Harmsworth [7].

Core Points - Spark Energy Minerals Inc. has received approval from the Canadian Securities Exchange to extend the expiry date of 2,241,668 common share purchase warrants from January 31, 2025, to February 22, 2026 [1][2] - The extension aligns with the end of the company's warrant incentive program, allowing holders additional time to participate before its conclusion on February 22, 2026 [2] - During the incentive program, the exercise price of the January Warrants is reduced to $0.05, and each holder who exercises their warrants will receive an additional common share purchase warrant at a price of $0.06 per share [2] Company Overview - Spark Energy Minerals Inc. is focused on the exploration and development of critical minerals essential for the clean-energy transition, primarily in Brazil [4] - The company controls a significant land position in Brazil's Lithium Valley, which is recognized for its lithium, gallium, and rare-earth potential [4] - The flagship Arapaima Project spans approximately 91,900 hectares and hosts multiple targets for lithium and gallium-REE mineralization [4]

Core Viewpoint - Nations Royalty Corp. has successfully closed a private placement offering, raising gross proceeds of C$15,000,000 through the sale of 9,375,000 units at a price of C$1.60 per unit, including the full exercise of the over-allotment option [1] Group 1: Offering Details - The offering consisted of units, each comprising one common share and one-half of a common share purchase warrant, with each whole warrant allowing the purchase of one common share at C$2.25 until January 30, 2029 [1] - Red Cloud Securities Inc. and Canaccord Genuity Corp. acted as underwriters, receiving cash fees of C$873,600 and 546,000 non-transferable common share purchase warrants as compensation [2] Group 2: Regulatory Compliance - The units were issued to Canadian purchasers under the listed issuer financing exemption, making them immediately freely tradeable in accordance with Canadian securities legislation [3] - The closing of the offering is subject to final approval from the TSX Venture Exchange [4] Group 3: Company Vision and Mission - Nations Royalty aims to unite First Nations and Indigenous groups across Canada, inviting external investors to participate as shareholders, thereby combining royalties and income from resource projects [6] - The company focuses on economic reconciliation and capacity building for Indigenous Peoples in public companies and capital markets [6] Group 4: Properties and Benefits - Nations Royalty has established five annual benefit payment entitlements related to various properties in Canada, including the Brucejack gold mine and the KSM Copper-Gold-Silver-Molybdenum deposit [7]

Core Viewpoint - Rakovina Therapeutics Inc. is undergoing significant corporate updates, including leadership changes, debt restructuring, and financing initiatives to strengthen governance and enhance capital markets execution [1]. Debt Restructuring - The maturity date of the 12.0% convertible debentures, totaling $1,454,000, has been extended from January 28, 2026, to March 11, 2026, with consent from holders representing at least 66 2/3% of the outstanding principal [2][3]. - The company plans to restructure the outstanding 2023 Debentures, offering holders the option to convert their debentures into new Replacement Debentures or settle through a shares-for-debt conversion at $0.12 per share [4][5]. - An agreement in principle has been reached with an existing investor for an additional $1.0 million investment through a private placement of unsecured convertible debentures [7]. Financing Initiatives - The company proposes a concurrent private placement of up to 5,000,000 common shares at $0.12 per share, aiming for additional gross proceeds of up to $500,000 [9]. - The proceeds from the private placements will be used for near-term working capital to support ongoing corporate activities and strategic initiatives [10]. Leadership Changes - Kim Oishi has been appointed as the new Chief Executive Officer and will also join the Board of Directors, bringing extensive experience in public company leadership and capital markets strategy [11][12]. - Frank Holler has been appointed as an independent director, contributing significant expertise in life sciences and governance [16][18][21]. - Jeffrey Bacha will continue as the non-executive Chair of the Board, ensuring continuity and strategic oversight [13][15]. Board Composition - Dr. Dennis Brown has stepped down from the Board but will continue as Chair of the Scientific Advisory Committee, while Al DeLucrezia has also stepped down but will remain as an advisor [23][24]. - The Board's recent changes are aimed at enhancing governance and supporting the company's strategic initiatives in oncology [25][26]. Company Overview - Rakovina Therapeutics is focused on developing innovative cancer treatments that target the DNA damage response, utilizing advanced computational chemistry and AI-enabled drug discovery platforms [27].